Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU6V | ISIN: US1897631057 | Ticker-Symbol: C97
Tradegate
28.03.25
21:54 Uhr
0,290 Euro
+0,010
+3,57 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CO-DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
CO-DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2780,29416:30
0,2800,28816:03

Aktuelle News zur CO-DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CO-DIAGNOSTICS Aktie jetzt für 0€ handeln
DoCo-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa3
DoCo-Diagnostics, Inc. Reports Full Year 2024 Financial Results70SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the...
► Artikel lesen
DoCo-Diagnostics, Inc. - 10-K, Annual Report2
DoCo-Diagnostics, Inc. - 8-K, Current Report1
MiUncovering Potential: Co-Diagnostics' Earnings Preview2
24.02.Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version3
21.02.Co-Diagnostics, Inc. - 8-K, Current Report-
21.02.Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance152The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/...
► Artikel lesen
10.01.Co-Diagnostics, Inc. - 8-K, Current Report-
07.11.24Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results172SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
07.11.24Co-Diagnostics, Inc. - 10-Q, Quarterly Report-
07.11.24Co-Diagnostics, Inc. - 8-K, Current Report-
06.11.24Co-Diagnostics Q3 2024 Earnings Preview1
08.08.24Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results259SALT LAKE CITY, August 8, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
► Artikel lesen
09.05.24Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results861SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1